Covishield
SII to supply 90 to 100 million Covishield doses in June: Report
Pune/IBNS: The Serum Institute of India (SII) has said it will be able to manufacture and supply 90 to 100 million doses of Covishield in June, media reports said.
SII has informed the government that it has ramped up its production capacity and will be able to supply nine to 10 crore doses of Covishield in June as compared to 6.5 crore in May.
Several states, including Punjab, Kerala, Maharashtra, Punjab, Andhra Pradesh, Rajasthan, Uttarakhand and Karnataka, among others, have invited global tenders for Covid-19 vaccines as shortage of jabs forced states to suspend vaccination centres.
SII on Sunday informed the government that its production capacity will be increased to 65 million in June, 70 million in July and 100 million in August.
The Union Health ministry on Sunday said that so far 212 million doses have been administered across the country.
Since May 1, 18.3 million people in the afe group 18-44 have been vaccinated.
India is currently using Bharat Biotech'Covaxin and Serum Institute of India manufactured Covishield, while Russia's Sputnik V is tge third vaccine which has recived approval for use in the country.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
